Immediate Alerts. Faster Care.
Automate ICH Detection and Receive Instant Physician Alerts for Quicker, More Informed Stroke Care.
Trusted by
Time is Brain: Every Second Counts
Of stroke patients are treated within the golden hour.
Delay leads to preventable disability.
Of stroke survivors face long-term disabilities.
Early intervention preserves mobility and function.
Minutes 120 M neurons, & 714 km of fibers degenerate.
Manual review is slow—AI speeds up detection
NeuroICH provides rapid, AI-powered analysis of non-contrast head CT scans to detect suspected intracranial hemorrhage. Instant notifications and non-diagnostic image previews are sent to mobile devices, enabling specialists to make quick, life-saving decisions.
Receive timely alerts to support informed clinical decisions
Access all essential patient information comprehensively
View Scans via versatile tools for multi-modality image analysis
Advanced AI algorithm to identify ICH with high accuracy
Tailor your searches with our advanced filter settings to ensure that you are only presented with the most relevant information.
Instantly access a comprehensive list of medical facilities and diagnostic centers to effortlessly review real-time patient data and imaging from diverse systems and sites.
NeuroICH™ leverages AI to drastically cut diagnosis time after a stroke, aiming for treatment within the 'golden hour' to prevent severe damage and disability.
NeuroICH™ accelerates diagnosis, improving survival rates and reducing disabilities, thus decreasing reliance on long-term care.
NeurolCH™’ helps preserve key functions like mobility and speech, reducing the risk of severe disabilities and improving recovery.
NeuroICH™ promotes quicker recovery, easing family stress and improving societal contributions by reducing long-term care needs.
NeuroICH™ is an AI-powered solution designed to detect intracranial hemorrhage (ICH) on CT brain scans. It instantly alerts physicians, accelerating diagnosis and treatment within the critical golden hour to improve patient outcomes.
NeuroICH™ uses an advanced AI algorithm with a sensitivity of 94.81% and specificity of 92.53%, providing reliable and timely detection of brain hemorrhage.
NeuroICH™ delivers immediate real-time alerts, with notifications sent to clinicians in under 30 seconds after scan acquisition.
Yes, NeuroICH™ is FDA 510(k) cleared and is both HIPAA and HITRUST certified, ensuring high standards of safety and data security.
NeuroICH™ enables rapid intervention, reduces the risk of disability, and improves recovery rates. Early detection means less reliance on long-term care and greater preservation of key functions like mobility and speech.
It streamlines assessment by providing instant notifications and one-click access to patient studies and essential information. This results in faster decision-making and greater work efficiency for radiologists.
NeuroICH™ adheres to stringent compliance requirements, featuring advanced cybersecurity, HIPAA compliance, and HITRUST certification to safeguard sensitive medical information.
Yes, NeuroICH™ supports both centralized and distributed care networks (hub & spoke model) for coordinated responses, making it adaptable for various hospital configurations.
By improving workflow and diagnostic efficiency, NeuroICH™ can contribute to higher profit margins, early treatment cost savings, and better resource utilization in stroke-certified hospitals.
Delayed diagnosis is a leading cause of preventable disability. Each hour without treatment can result in the loss of up to 120 million neurons and 714 km of neural fibers, emphasizing the need for real-time AI solutions like NeuroICH™.
Subscribe to our White Paper for the latest updates, insights, and exclusive resources delivered straight to your inbox.